Literature DB >> 16855800

Specific targeting of pancreatic islet cells in vivo by insulin-promoter-driven adenoviral conjugated reporter genes.

Xiaoping Wang1, Elizabeth Olmsted-Davis, Alan Davis, Shihe Liu, Zhijun Li, Jie Yang, F Charles Brunicardi.   

Abstract

BACKGROUND: The objective of this study was to determine whether rat insulin promoter (RIP) could, in a mouse model, direct expression of an adenovirus-mediated reporter gene specifically into pancreatic islets via systemic delivery.
METHODS: Five hundred and eight base pairs of the RIP DNA sequence were constructed into an adenoviral vector containing a lacZ reporter gene (Adeno-RIP-lacZ). The cytomegalovirus (CMV) promoter was constructed to drive lacZ reporter-gene expression (Adeno-CMV-lacZ) and used as controls. In vitro transient transfection assays were performed to determine levels of reporter-gene expression and compared with that of liposome-mediated plasmid transfection. SCID mice were bred and housed in the barrier BL-4 animal facility. At 2 months of age, the human pancreatic cancer cell PANC-1 was intraperitoneally injected into male mice. Two months after the tumor cell inoculation, mice were injected with 10(7) adenoviral particles via tail veins. After gene delivery, mice were sacrificed at different time points to determine transgene expression levels. Complete necropsies were performed. Morphological alterations were determined using hematoxylin and eosin (H&E) staining, and distribution of the reporter lacZ gene was determined by immunohistochemistry analyses.
RESULTS: Adenoviral-driven reporter-gene expression resulted in more than 5 times higher transgene expression compared with conventional plasmid transfections. In Adeno-RIP-lacZ-injected mice, lacZ expression was specifically detected in pancreatic islets. By contrast, in Adeno-CMV-lacZ-injected mice, lacZ gene expression was observed in multiple organs and tissues. Mononuclear cell infiltration and liver cell inflammation were found in Adeno-CMV-lacZ-treated mice. Similar phenomena were observed in islet cells of Adeno-RIP-lacZ-treated mice. A significantly higher level of reporter-gene expression was also found at the edge of in-vivo-inoculated human pancreatic tumors.
CONCLUSION: These results demonstrate that RIP-directed reporter-gene expression was found specifically in mouse pancreatic islets and implanted human pancreatic cancer cells. These data thus demonstrate that the combination of an adenoviral vector and a tissue-specific promoter could lead to an enhanced and more specific transgene expression in vivo.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16855800     DOI: 10.1007/s00268-005-0688-3

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  41 in total

1.  Beta-cell differentiation from a human pancreatic cell line in vitro and in vivo.

Authors:  D de la Tour; T Halvorsen; C Demeterco; B Tyrberg; P Itkin-Ansari; M Loy; S J Yoo; E Hao; S Bossie; F Levine
Journal:  Mol Endocrinol       Date:  2001-03

2.  Adenovirus-mediated wild-type p53 tumor suppressor gene therapy induces apoptosis and suppresses growth of human pancreatic cancer [seecomments].

Authors:  M Bouvet; R J Bold; J Lee; D B Evans; J L Abbruzzese; P J Chiao; D J McConkey; J Chandra; S Chada; B Fang; J A Roth
Journal:  Ann Surg Oncol       Date:  1998-12       Impact factor: 5.344

3.  Clinical utility of CEA, CA 19-9, and CA 72-4 in the follow-up of patients with resectable gastric cancer.

Authors:  D Marrelli; E Pinto; A De Stefano; M Farnetani; L Garosi; F Roviello
Journal:  Am J Surg       Date:  2001-01       Impact factor: 2.565

4.  Applying the herpes simplex virus thymidine kinase/ganciclovir approach to ovarian cancer: an effective in vitro drug-sensitization system.

Authors:  A Al-Hendy; N Auersperg
Journal:  Gynecol Obstet Invest       Date:  1997       Impact factor: 2.031

5.  A mutational analysis of the insulin gene transcription control region: expression in beta cells is dependent on two related sequences within the enhancer.

Authors:  O Karlsson; T Edlund; J B Moss; W J Rutter; M D Walker
Journal:  Proc Natl Acad Sci U S A       Date:  1987-12       Impact factor: 11.205

6.  Modulation of rat pancreatic acinoductal transdifferentiation and expression of PDX-1 in vitro.

Authors:  I Rooman; Y Heremans; H Heimberg; L Bouwens
Journal:  Diabetologia       Date:  2000-07       Impact factor: 10.122

7.  Glucose modulation of insulin mRNA levels is dependent on transcription factor PDX-1 and occurs independently of changes in intracellular Ca2+.

Authors:  W M Macfarlane; R M Shepherd; K E Cosgrove; R F James; M J Dunne; K Docherty
Journal:  Diabetes       Date:  2000-03       Impact factor: 9.461

8.  Role of carcinoembryonic antigen in the progression of colon cancer cells that express carbohydrate antigen.

Authors:  S Minami; J Furui; T Kanematsu
Journal:  Cancer Res       Date:  2001-03-15       Impact factor: 12.701

9.  Specific gene expression and therapy for pancreatic cancer using the cytosine deaminase gene directed by the rat insulin promoter.

Authors:  Xiao-Ping Wang; Kazuyuki Yazawa; Jie Yang; Deborah Kohn; William E Fisher; F Charles Brunicardi
Journal:  J Gastrointest Surg       Date:  2004-01       Impact factor: 3.452

Review 10.  PDX-1 and the pancreas.

Authors:  Satoshi Ashizawa; F Charles Brunicardi; Xiao-Ping Wang
Journal:  Pancreas       Date:  2004-03       Impact factor: 3.327

View more
  4 in total

Review 1.  Matrices and scaffolds for DNA delivery in tissue engineering.

Authors:  Laura De Laporte; Lonnie D Shea
Journal:  Adv Drug Deliv Rev       Date:  2007-04-14       Impact factor: 15.470

2.  Mitochondrial imaging in dorsal root ganglion neurons following the application of inducible adenoviral vector expressing two fluorescent proteins.

Authors:  Payman Nasr; Patrick G Sullivan; George M Smith
Journal:  J Neurosci Methods       Date:  2008-05-03       Impact factor: 2.390

3.  Multiple treatment cycles of liposome-encapsulated adenoviral RIP-TK gene therapy effectively ablate human pancreatic cancer cells in SCID mice.

Authors:  Shi-He Liu; Nancy Smyth-Templeton; Alan R Davis; Elizabeth A Davis; Nikiforos Ballian; Min Li; Hao Liu; William Fisher; F Charles Brunicardi
Journal:  Surgery       Date:  2011-02-05       Impact factor: 3.982

4.  Liposomal insulin promoter-thymidine kinase gene therapy followed by ganciclovir effectively ablates human pancreatic cancer in mice.

Authors:  James X Wu; Shi-He Liu; John J Nemunaitis; F Charles Brunicardi
Journal:  Cancer Lett       Date:  2015-01-14       Impact factor: 8.679

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.